Safety assessment of drug combinations used in COVID-19 treatment: in silico toxicogenomic data-mining approach

Improvement of COVID-19 clinical condition was seen in studies where combination of antiretroviral drugs, lopinavir and ritonavir, as well as immunomodulant antimalaric, chloroquine/hydroxychloroquine together with the macrolide-type antibiotic, azithromycin, was used for patient's treatment. A...

Descripción completa

Detalles Bibliográficos
Autores principales: Baralić, Katarina, Jorgovanović, Dragica, Živančević, Katarina, Antonijević Miljaković, Evica, Antonijević, Biljana, Buha Djordjevic, Aleksandra, Ćurčić, Marijana, Đukić-Ćosić, Danijela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7483129/
https://www.ncbi.nlm.nih.gov/pubmed/32920000
http://dx.doi.org/10.1016/j.taap.2020.115237

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7483129/
https://www.ncbi.nlm.nih.gov/pubmed/32920000
http://dx.doi.org/10.1016/j.taap.2020.115237

Ejemplares similares